LataMed AI Begins Evaluating Global Healthcare Expansion Opportunities Through Planned Attendance at World Health Expo 2027
CARACAS, VENEZUELA - July 13, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that management has begun planning for the Company's anticipated attendance at the World Health Expo 2027 in Dubai, United Arab Emirates, as part of its broader strategy to evaluate international healthcare expansion opportunities. Management believes attendance at World Health Expo 2027 will provide an important opportunity to engage with healthcare leaders, technology innovators, healthcare providers, government representatives, and potential strategic partners from around the world while evaluating opportunities beyond the Company's current Latin American initiatives. The Company believes its planned participation is intended to support ongoing assessments of international commercialization opportunities for its developing digital healthcare ecosystem, including telehealth infrastructure, healthcare coordination technologies, pharmacy integration initiatives, insurance acc
Free plan · Plus CA$29 or Pro CA$99/month


